Substrate based inhibitors of smooth muscle myosin light chain kinase.
Activation of myosin light chain kinase is a prerequisite for smooth muscle activation. In this study, short peptide analogs of the phosphorylation site of the myosin light chain were studied for their effects on several contractile protein systems. The peptides inhibited phosphorylation of isolated ventricular and smooth muscle myosin light chains by smooth muscle myosin light chain kinase, but they were only weak inhibitors of phosphorylation of intact myosin and actomyosin. The peptides were also unable to block force development or myosin light chain phosphorylation in glycerol permeabilized fibers of swine carotid media. Apparently, the association of the myosin light chain with myosin changes its conformation such that substrate analogs which are potent inhibitors of the phosphorylation of isolated myosin light chains by myosin light chain kinase are ineffective at blocking phosphorylation of the intact molecule.
Moreland
S
S
Department of Pharmacology, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ 08543.
Ikebe
M
M
Hunt
J T
JT
Moreland
R S
RS
D000595:Amino Acid Sequence; D000818:Animals; D001011:Aorta / Q000378:metabolism; D002339:Carotid Arteries / Q000378:metabolism; D002417:Cattle; D002645:Chickens; D004305:Dose-Response Relationship, Drug; D005895:Gizzard, Avian / Q000201:enzymology; D008969:Molecular Sequence Data; D009130:Muscle, Smooth / Q000201:enzymology*; D009131:Muscle, Smooth, Vascular / Q000201:enzymology; D009219:Myosin-Light-Chain Kinase / Q000037:antagonists & inhibitors*; D009218:Myosins / Q000378:metabolism*; D009842:Oligopeptides / Q000494:pharmacology; D010766:Phosphorylation; D013552:Swine
D009842:Oligopeptides; D009219:Myosin-Light-Chain Kinase; D009218:Myosins